Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model

被引:0
|
作者
Rupsha Mondal
Chayan Banerjee
Sumangal Nandy
Moumita Roy
Joy Chakraborty
机构
[1] CSIR-Indian Institute of Chemical Biology,
[2] Academy of Scientific and Innovative Research (AcSIR),undefined
来源
关键词
Dopamine toxicity; Mitochondrial fragmentation; Calcineurin; Parkinson’s disease; L-DOPA therapy; Dendritic spine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] DOCOSAHEXAENOIC ACID PROTECTS AGAINST PARKINSON'S DISEASE
    Tang, K. S.
    GLIA, 2011, 59 : S81 - S82
  • [22] INHIBITION OF PROTEIN DISULPHIDE ISOMERASE AND CONSECUTIVE ENHANCEMENT OF AUTOPHAGY PROTECTS AGAINST PROTEIN AGGREGATION INDUCED TOXICITY IN MODELS OF PARKINSON'S DISEASE
    Lehtonen, S.
    Jaronen, M.
    Ainen, Vehvil P.
    Laakso, M.
    Keksa-Goldsteine, V
    Wong, G.
    Courtney, M.
    Koistinaho, J.
    Goldsteins, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 198 - 198
  • [23] Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease
    Chao, Yin Xia
    He, Bei Ping
    Tay, Samuel Sam Wah
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 216 (1-2) : 39 - 50
  • [24] Dopamine-related behavioral disorders in Parkinson's disease
    Hui, JS
    Lew, MF
    MOVEMENT DISORDERS, 2004, 19 : S280 - S280
  • [25] Tuning beneficial calcineurin phosphatase activation to counter α-synuclein toxicity in a yeast model of Parkinson's disease
    Srishti Chawla
    Mikael Molin
    Thomas Nystrom
    Neural Regeneration Research, 2025, (01) : 199 - 200
  • [26] Tuning beneficial calcineurin phosphatase activation to counter α-synuclein toxicity in a yeast model of Parkinson's disease
    Chawla, Srishti
    Molin, Mikael
    Nystrom, Thomas
    NEURAL REGENERATION RESEARCH, 2025, 20 (01) : 199 - 200
  • [27] Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model
    Wang, Wenzhang
    Yin, Jun
    Ma, Xiaopin
    Zhao, Fanpeng
    Siedlak, Sandra L.
    Wang, Zhenlian
    Torres, Sandy
    Fujioka, Hisashi
    Xu, Ying
    Perry, George
    Zhu, Xiongwei
    HUMAN MOLECULAR GENETICS, 2017, 26 (21) : 4118 - 4131
  • [28] Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease
    Wang, Yong
    Yao, Lu
    Gao, Shasha
    Zhang, Gejuan
    Zhang, Qiongchi
    Liu, Wanyuan
    Zhou, Yingqiong
    Sun, Yina
    Feng, Jie
    Liu, Jian
    BRAIN RESEARCH, 2021, 1754
  • [29] Pharmacological inhibition of AIMP2 aggregation attenuates ?-synuclein aggregation and toxicity in Parkinson?s disease
    Shin, Jeong-Yong
    Lee, Bina
    Ham, Sangwoo
    Kim, Ji Hun
    Kim, Hyojung
    Kim, Heejeong
    Jo, Min Gi
    Kim, Hye Jung
    Park, Sang Won
    Kweon, Hee-Seok
    Kim, Yong Jun
    Yun, Seung Pil
    Lee, Yunjong
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [30] Vesicular monoamine transport, dopamine toxicity and Parkinson's disease
    Edwards, R
    Fon, E
    Merickel, A
    Finn, P
    Krantz, D
    Liu, Y
    FASEB JOURNAL, 1997, 11 (09): : A869 - A869